CEFUROXIME AXETIL

CEFUROXIME AXETIL was reported 3502 times

CEFUROXIME AXETIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VERTEBRAL END PLATE INFLAMMATION 11 0.5500
1 TRIMETHYLAMINURIA 17 0.4146
2 CAPILLARITIS 74 0.2681
3 ANTERIOR CHAMBER PIGMENTATION 5 0.2500
4 PULMONARY VASCULITIS 121 0.2249
5 TOTAL LUNG CAPACITY ABNORMAL 77 0.1979
6 SPIROMETRY ABNORMAL 86 0.1438
7 MITE ALLERGY 86 0.1313
8 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 79 0.1078
9 MYCOTIC ALLERGY 85 0.0994
10 DUST ALLERGY 86 0.0877
11 NEURITIS 116 0.0751
12 MACULAR DETACHMENT 18 0.0744
13 SPUTUM PURULENT 46 0.0699
14 DELAYED DARK ADAPTATION 5 0.0676
15 CONJUNCTIVITIS ALLERGIC 97 0.0655
16 RETINOSCHISIS 9 0.0652
17 SLEEP INERTIA 5 0.0515
18 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 104 0.0510
19 OESOPHAGEAL SPASM 92 0.0499
20 HEART SOUNDS 4 0.0417
21 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 3 0.0411
22 RESPIRATORY SYMPTOM 116 0.0407
23 SECONDARY IMMUNODEFICIENCY 43 0.0354
24 ENCEPHALITIS FUNGAL 3 0.0333
25 RETINAL INFARCTION 8 0.0325
26 OESOPHAGITIS HAEMORRHAGIC 9 0.0320
27 NORMOCHROMIC NORMOCYTIC ANAEMIA 91 0.0303
28 FORCED EXPIRATORY VOLUME DECREASED 76 0.0268
29 ANTERIOR CHAMBER INFLAMMATION 15 0.0252
30 OESOPHAGEAL PAIN 95 0.0240
31 SEROUS RETINAL DETACHMENT 19 0.0227
32 SPINAL MUSCULAR ATROPHY 6 0.0222
33 COLOUR BLINDNESS ACQUIRED 8 0.0220
34 PULMONARY ALVEOLAR HAEMORRHAGE 120 0.0214
35 LYMPHOEDEMA 144 0.0208
36 OBSTRUCTIVE SLEEP APNOEA SYNDROME 30 0.0206
37 NEUROLOGICAL SYMPTOM 115 0.0201
38 ALLERGIC OEDEMA 12 0.0185
39 SICK LEAVE 4 0.0178
40 RETINAL TOXICITY 18 0.0175
41 DYSBIOSIS 14 0.0171
42 BACTERIAL TEST 5 0.0168
43 OBSTRUCTIVE AIRWAYS DISORDER 170 0.0153
44 ARTERIOSCLEROSIS CORONARY ARTERY 97 0.0146
45 OCULAR TOXICITY 16 0.0145
46 FULL BLOOD COUNT ABNORMAL 140 0.0132
47 CORNEAL OEDEMA 29 0.0129
48 MOTOR NEURONE DISEASE 6 0.0123
49 KOUNIS SYNDROME 28 0.0123
50 PRODUCT IMPURITY 3 0.0109
51 MEGACOLON 17 0.0108
52 THERAPEUTIC PRODUCT CROSS-REACTIVITY 9 0.0101
53 RESPIRATORY TRACT INFECTION BACTERIAL 5 0.0100
54 VASCULITIS 116 0.0099
55 STOMA CLOSURE 3 0.0096
56 ARTERIOSCLEROSIS 89 0.0094
57 PSEUDOMEMBRANOUS COLITIS 21 0.0094
58 TOXIC ANTERIOR SEGMENT SYNDROME 10 0.0092
59 JARISCH-HERXHEIMER REACTION 6 0.0084
60 PRODUCT PREPARATION ISSUE 52 0.0079
61 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 4 0.0078
62 CLOSTRIDIUM TEST POSITIVE 17 0.0077
63 MACULAR OEDEMA 43 0.0077
64 PNEUMOCOCCAL SEPSIS 5 0.0076
65 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 129 0.0076
66 INHIBITORY DRUG INTERACTION 12 0.0076
67 WHITE BLOOD CELLS URINE POSITIVE 14 0.0074
68 FIBROMYALGIA 172 0.0071
69 SKIN OEDEMA 7 0.0070
70 LACRIMAL DISORDER 4 0.0069
71 PLEOCYTOSIS 4 0.0069
72 PULMONARY ARTERY STENOSIS CONGENITAL 5 0.0068
73 NODULE 89 0.0068
74 EOSINOPHIL COUNT ABNORMAL 5 0.0067
75 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
76 CYSTOID MACULAR OEDEMA 12 0.0064
77 PULMONARY FIBROSIS 122 0.0064
78 BLOOD CHOLESTEROL 3 0.0063
79 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 16 0.0060
80 SENSE OF OPPRESSION 7 0.0059
81 BACTERIAL TEST POSITIVE 13 0.0058
82 RETINAL OEDEMA 11 0.0057
83 JOINT NOISE 11 0.0056
84 CONGENITAL HYDRONEPHROSIS 4 0.0056
85 MEASLES 3 0.0056
86 NICOTINE DEPENDENCE 43 0.0055
87 SLEEP APNOEA SYNDROME 99 0.0052
88 RETINAL INJURY 4 0.0052
89 ISCHAEMIC CEREBRAL INFARCTION 6 0.0052
90 CROSS SENSITIVITY REACTION 5 0.0051
91 NASAL DISCHARGE DISCOLOURATION 7 0.0051
92 SPONDYLOARTHROPATHY 3 0.0050
93 BREATH ODOUR 12 0.0049
94 PRODUCT COATING ISSUE 5 0.0049
95 CYSTITIS 156 0.0049
96 ILLUSION 8 0.0048
97 GLOMERULOSCLEROSIS 3 0.0047
98 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
99 HAEMOPTYSIS 128 0.0046
100 BRONCHIAL DISORDER 7 0.0045
101 FEAR OF DISEASE 8 0.0045
102 MUCOSAL EROSION 4 0.0044
103 HAEMOLYTIC URAEMIC SYNDROME 10 0.0043
104 SJS-TEN OVERLAP 3 0.0043
105 MACULOPATHY 15 0.0042
106 PYELOCALIECTASIS 4 0.0042
107 EPIDERMAL NECROSIS 4 0.0041
108 HYPOSMIA 6 0.0040
109 CONJUNCTIVAL OEDEMA 4 0.0039
110 RETINAL PIGMENTATION 3 0.0038
111 HYPOTHYROIDISM 120 0.0038
112 SWOLLEN TONGUE 116 0.0037
113 SUBRETINAL FLUID 4 0.0037
114 LEUKOCYTURIA 3 0.0036
115 RESUSCITATION 6 0.0036
116 PLANTAR FASCIITIS 12 0.0036
117 DENTAL DISCOMFORT 3 0.0036
118 AUDITORY DISORDER 5 0.0035
119 UPPER RESPIRATORY TRACT INFLAMMATION 4 0.0033
120 ORAL MUCOSAL EXFOLIATION 5 0.0033
121 TYPE IV HYPERSENSITIVITY REACTION 9 0.0033
122 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
123 WHEEZING 191 0.0032
124 SKIN TEST POSITIVE 3 0.0032
125 LUNG CONSOLIDATION 9 0.0032
126 HYPERPARATHYROIDISM SECONDARY 8 0.0032
127 LIMB MASS 7 0.0032
128 MIDDLE EAR EFFUSION 7 0.0032
129 RED BLOOD CELLS URINE POSITIVE 3 0.0031
130 LYMPHADENECTOMY 3 0.0031
131 HYPOXIA 108 0.0031
132 HYPOGEUSIA 6 0.0031
133 MATERNAL EXPOSURE DURING DELIVERY 3 0.0030
134 LYME DISEASE 10 0.0030
135 BODY MASS INDEX INCREASED 4 0.0030
136 FLUID RETENTION 149 0.0029
137 SUBDURAL HAEMORRHAGE 8 0.0029
138 TYPE I HYPERSENSITIVITY 10 0.0028
139 SLEEP DEFICIT 6 0.0028
140 DIVERTICULUM 20 0.0028
141 SPUTUM INCREASED 6 0.0028
142 INCREASED BRONCHIAL SECRETION 7 0.0027
143 ANGIOEDEMA 121 0.0027
144 PAROSMIA 20 0.0026
145 GRANULOCYTOPENIA 15 0.0026
146 KERATITIS 8 0.0026
147 BLOOD FIBRINOGEN DECREASED 3 0.0026
148 BLOOD PRESSURE IMMEASURABLE 4 0.0026
149 PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0026
150 NEPHROGENIC ANAEMIA 12 0.0026
151 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 184 0.0026
152 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 124 0.0026
153 ANAPHYLACTIC SHOCK 66 0.0026
154 LUNG DISORDER 124 0.0025
155 BRONCHITIS 187 0.0025
156 MULTIMORBIDITY 3 0.0025
157 INFECTED CYST 3 0.0025
158 TOXIC EPIDERMAL NECROLYSIS 38 0.0025
159 OXYGEN SATURATION ABNORMAL 7 0.0025
160 CRYPTOCOCCOSIS 4 0.0025
161 PENILE SWELLING 3 0.0024
162 RETINOPATHY 9 0.0024
163 LINEAR IGA DISEASE 4 0.0024
164 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 4 0.0024
165 PROTEIN TOTAL DECREASED 9 0.0024
166 TINNITUS 109 0.0024
167 BILIARY DYSKINESIA 4 0.0024
168 PRODUCTIVE COUGH 112 0.0023
169 NOCARDIOSIS 6 0.0023
170 ANAPHYLACTIC REACTION 127 0.0023
171 NOSOCOMIAL INFECTION 5 0.0023
172 CYSTITIS NONINFECTIVE 3 0.0022
173 STAPHYLOCOCCAL SEPSIS 11 0.0022
174 RHONCHI 3 0.0022
175 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
176 ENDOPHTHALMITIS 13 0.0022
177 MENISCUS LESION 3 0.0022
178 ANAL HAEMORRHAGE 6 0.0021
179 PROTHROMBIN TIME SHORTENED 3 0.0021
180 AGITATION 154 0.0021
181 DYSPHONIA 120 0.0020
182 ABDOMINAL WALL HAEMATOMA 4 0.0020
183 URINE ODOUR ABNORMAL 12 0.0020
184 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
185 HALLUCINATION 151 0.0020
186 CARDIAC DISCOMFORT 4 0.0020
187 PRODUCT SOLUBILITY ABNORMAL 10 0.0020
188 BLOOD COUNT ABNORMAL 30 0.0020
189 CHEST X-RAY ABNORMAL 6 0.0020
190 SWELLING FACE 126 0.0019
191 ENTHESOPATHY 3 0.0019
192 OPTIC ATROPHY 3 0.0018
193 ASTHMA 204 0.0018
194 CHOLESTATIC LIVER INJURY 4 0.0018
195 CLOSTRIDIAL INFECTION 6 0.0018
196 SPLEEN DISORDER 3 0.0018
197 HAEMATOCRIT INCREASED 4 0.0018
198 FIXED ERUPTION 3 0.0017
199 KIDNEY FIBROSIS 3 0.0017
200 BILIRUBIN CONJUGATED INCREASED 4 0.0017
201 DEMYELINATION 7 0.0017
202 THROMBOTIC THROMBOCYTOPENIC PURPURA 6 0.0017
203 END STAGE RENAL DISEASE 31 0.0017
204 CREPITATIONS 5 0.0017
205 MIGRAINE 160 0.0017
206 PREMATURE RUPTURE OF MEMBRANES 4 0.0017
207 CLOSTRIDIUM DIFFICILE INFECTION 36 0.0016
208 DRUG INTOLERANCE 159 0.0016
209 NASAL POLYPS 8 0.0016
210 DIASTOLIC DYSFUNCTION 5 0.0016
211 HYPERACUSIS 6 0.0016
212 INTESTINAL PERFORATION 18 0.0016
213 TACHYARRHYTHMIA 4 0.0016
214 SACROILIITIS 3 0.0016
215 STOMATITIS 96 0.0016
216 URINARY TRACT INFECTION BACTERIAL 4 0.0016
217 RASH MACULO-PAPULAR 35 0.0016
218 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
219 CONJUNCTIVAL HAEMORRHAGE 6 0.0016
220 ORTHOPNOEA 5 0.0016
221 HEPATOSPLENOMEGALY 4 0.0016
222 MEAN CELL VOLUME INCREASED 4 0.0016
223 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0015
224 HYPERSENSITIVITY VASCULITIS 4 0.0015
225 NEPHRITIS 5 0.0015
226 DEVICE RELATED SEPSIS 3 0.0015
227 INTRAOCULAR PRESSURE INCREASED 19 0.0015
228 WEIGHT BEARING DIFFICULTY 4 0.0015
229 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 81 0.0015
230 SCOLIOSIS 9 0.0015
231 INTESTINAL ISCHAEMIA 8 0.0015
232 FORMICATION 10 0.0014
233 PSYCHOMOTOR RETARDATION 4 0.0014
234 CHRONIC KIDNEY DISEASE 107 0.0014
235 C-REACTIVE PROTEIN ABNORMAL 9 0.0014
236 HYPERHIDROSIS 180 0.0014
237 LYMPHOCYTOSIS 3 0.0014
238 TENDON DISORDER 9 0.0014
239 CEREBRAL ISCHAEMIA 7 0.0014
240 TOOTH DISCOLOURATION 4 0.0014
241 DERMATITIS ALLERGIC 17 0.0014
242 FEAR OF DEATH 3 0.0013
243 IRON DEFICIENCY 6 0.0013
244 THROAT CLEARING 5 0.0013
245 REBOUND ACID HYPERSECRETION 4 0.0013
246 DISEASE COMPLICATION 6 0.0013
247 IMMUNE THROMBOCYTOPENIA 6 0.0013
248 ORAL PRURITUS 3 0.0013
249 CLAVICLE FRACTURE 5 0.0013
250 DYSAESTHESIA 4 0.0013
251 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
252 ORAL DISCOMFORT 18 0.0013
253 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
254 RESPIRATORY ACIDOSIS 5 0.0013
255 NEUTROPHIL COUNT INCREASED 13 0.0013
256 THROMBOSIS 102 0.0013
257 PUSTULE 3 0.0013
258 BRONCHOSPASM 18 0.0013
259 PULMONARY EMBOLISM 119 0.0013
260 VISUAL FIELD DEFECT 9 0.0012
261 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
262 HIATUS HERNIA 16 0.0012
263 BREATH SOUNDS ABNORMAL 6 0.0012
264 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
265 OTITIS MEDIA 4 0.0012
266 SUFFOCATION FEELING 3 0.0012
267 ANXIETY DISORDER 4 0.0012
268 CHOLECYSTITIS CHRONIC 8 0.0012
269 POTENTIATING DRUG INTERACTION 4 0.0012
270 HYPERSENSITIVITY 221 0.0012
271 TONGUE DISCOMFORT 5 0.0012
272 URTICARIA 196 0.0012
273 BRONCHOPNEUMONIA 4 0.0012
274 AORTIC ARTERIOSCLEROSIS 3 0.0012
275 ANXIETY 330 0.0012
276 ERYTHEMA NODOSUM 4 0.0011
277 LUNG INFILTRATION 10 0.0011
278 LYMPHOCYTE COUNT DECREASED 20 0.0011
279 PHYSICAL DISABILITY 5 0.0011
280 PRODUCT SIZE ISSUE 6 0.0011
281 MENINGITIS ASEPTIC 5 0.0011
282 RASH MORBILLIFORM 3 0.0011
283 MACULE 3 0.0011
284 ATRIAL SEPTAL DEFECT 9 0.0011
285 VAGINAL INFECTION 5 0.0011
286 TENDON PAIN 8 0.0011
287 ABDOMINAL PAIN 243 0.0010
288 KIDNEY TRANSPLANT REJECTION 5 0.0010
289 HERPES VIRUS INFECTION 6 0.0010
290 RASH VESICULAR 5 0.0010
291 METABOLIC DISORDER 6 0.0010
292 JOINT EFFUSION 7 0.0010
293 PERITONITIS 21 0.0010
294 BLOOD ALBUMIN DECREASED 8 0.0010
295 ABDOMINAL PAIN UPPER 207 0.0010
296 MYOSITIS 9 0.0010
297 MIXED LIVER INJURY 3 0.0010
298 RETINAL DETACHMENT 9 0.0010
299 PORTAL HYPERTENSION 3 0.0010
300 TALIPES 3 0.0010
301 ERYTHEMA MULTIFORME 9 0.0010
302 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
303 SPUTUM DISCOLOURED 9 0.0009
304 LIP OEDEMA 4 0.0009
305 ANORECTAL DISCOMFORT 5 0.0009
306 STUPOR 3 0.0009
307 HYPOVENTILATION 3 0.0009
308 TONGUE DISCOLOURATION 4 0.0009
309 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
310 HAEMOLYTIC ANAEMIA 8 0.0009
311 GOUT 16 0.0009
312 PRODUCT TASTE ABNORMAL 12 0.0009
313 PREMATURE LABOUR 5 0.0009
314 GENERALISED ERYTHEMA 5 0.0009
315 HYPOPNOEA 3 0.0009
316 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 22 0.0009
317 ESCHERICHIA INFECTION 7 0.0009
318 SLEEP DISORDER 60 0.0008
319 DRUG ERUPTION 15 0.0008
320 SKIN ABRASION 4 0.0008
321 RETINAL HAEMORRHAGE 6 0.0008
322 SINUS HEADACHE 5 0.0008
323 TASTE DISORDER 17 0.0008
324 EXPOSURE DURING PREGNANCY 52 0.0008
325 ATELECTASIS 8 0.0008
326 FOETAL GROWTH RESTRICTION 5 0.0008
327 CIRCULATORY COLLAPSE 14 0.0008
328 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
329 FOOD INTOLERANCE 3 0.0008
330 DEPRESSION 185 0.0008
331 PSYCHOLOGICAL TRAUMA 7 0.0008
332 TENDON RUPTURE 10 0.0008
333 MUCOUS STOOLS 4 0.0008
334 VISION BLURRED 110 0.0008
335 PRE-EXISTING CONDITION IMPROVED 5 0.0008
336 FLUID INTAKE REDUCED 4 0.0008
337 BRAIN INJURY 8 0.0008
338 ECONOMIC PROBLEM 12 0.0008
339 PARANASAL SINUS HYPERSECRETION 3 0.0008
340 ANAL INCONTINENCE 7 0.0008
341 EAR PAIN 15 0.0008
342 FAECES HARD 3 0.0008
343 PERIORBITAL OEDEMA 4 0.0008
344 SKIN EXFOLIATION 65 0.0008
345 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
346 LOW BIRTH WEIGHT BABY 6 0.0008
347 CEREBRAL ATROPHY 3 0.0008
348 ATRIAL FLUTTER 6 0.0008
349 FRUSTRATION TOLERANCE DECREASED 6 0.0007
350 SINUS CONGESTION 10 0.0007
351 TACHYPNOEA 10 0.0007
352 BODY TEMPERATURE INCREASED 15 0.0007
353 EYE INFLAMMATION 7 0.0007
354 RESPIRATION ABNORMAL 5 0.0007
355 HYPERCHOLESTEROLAEMIA 7 0.0007
356 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
357 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
358 RETCHING 15 0.0007
359 HEPATITIS 18 0.0007
360 MYOCARDIAL ISCHAEMIA 8 0.0007
361 IRRITABLE BOWEL SYNDROME 15 0.0007
362 ENTEROCOLITIS 4 0.0007
363 PANIC REACTION 5 0.0007
364 BLOOD URIC ACID INCREASED 4 0.0007
365 OCULAR ICTERUS 3 0.0007
366 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
367 HYPERVENTILATION 4 0.0007
368 RALES 4 0.0007
369 TEMPERATURE INTOLERANCE 7 0.0007
370 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
371 RESPIRATORY RATE INCREASED 6 0.0007
372 FEELING ABNORMAL 161 0.0007
373 PAIN IN EXTREMITY 197 0.0007
374 SYMPTOM RECURRENCE 4 0.0007
375 MUSCULOSKELETAL PAIN 35 0.0007
376 JOINT DISLOCATION 7 0.0007
377 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
378 CONDITION AGGRAVATED 199 0.0007
379 FACE OEDEMA 11 0.0007
380 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
381 OLIGURIA 4 0.0006
382 HYPOALBUMINAEMIA 5 0.0006
383 PELVIC FRACTURE 5 0.0006
384 PULMONARY HAEMORRHAGE 5 0.0006
385 WOUND INFECTION 7 0.0006
386 EAR INFECTION 17 0.0006
387 DRUG-INDUCED LIVER INJURY 20 0.0006
388 ABDOMINAL DISTENSION 66 0.0006
389 MUSCLE ATROPHY 8 0.0006
390 STEVENS-JOHNSON SYNDROME 14 0.0006
391 HYPOVOLAEMIC SHOCK 3 0.0006
392 OCULAR DISCOMFORT 7 0.0006
393 DRUG RESISTANCE 16 0.0006
394 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
395 PNEUMONIA 201 0.0006
396 GUILLAIN-BARRE SYNDROME 3 0.0006
397 RHINITIS 5 0.0006
398 THIRST 11 0.0006
399 RENAL FAILURE 81 0.0006
400 ANHEDONIA 16 0.0006
401 PHOTOSENSITIVITY REACTION 10 0.0006
402 DRUG INTERACTION 96 0.0006
403 ABDOMINAL TENDERNESS 3 0.0006
404 ANEURYSM 3 0.0006
405 EYELID OEDEMA 7 0.0006
406 MYOCARDIAL INFARCTION 105 0.0006
407 PROTEIN URINE PRESENT 3 0.0006
408 LIP SWELLING 20 0.0006
409 SINUSITIS 61 0.0006
410 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
411 SENSATION OF FOREIGN BODY 5 0.0006
412 COVID-19 PNEUMONIA 7 0.0006
413 DRY THROAT 6 0.0006
414 MOTOR DYSFUNCTION 6 0.0006
415 EAR DISCOMFORT 6 0.0006
416 MYALGIA 99 0.0006
417 ACUTE KIDNEY INJURY 89 0.0006
418 AUTOIMMUNE HEPATITIS 4 0.0006
419 PARTIAL SEIZURES 3 0.0006
420 EOSINOPHILIA 10 0.0006
421 SPINAL OSTEOARTHRITIS 5 0.0006
422 HERNIA 11 0.0006
423 DUODENAL ULCER 4 0.0006
424 NYSTAGMUS 3 0.0006
425 PURPURA 5 0.0006
426 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
427 PRURITUS 217 0.0006
428 SINUS TACHYCARDIA 8 0.0006
429 COMPRESSION FRACTURE 3 0.0006
430 SECRETION DISCHARGE 7 0.0006
431 JAUNDICE 15 0.0006
432 IMPAIRED QUALITY OF LIFE 8 0.0006
433 DISABILITY 11 0.0006
434 GINGIVITIS 3 0.0006
435 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
436 RESTLESSNESS 20 0.0005
437 DRUG LEVEL INCREASED 9 0.0005
438 UROSEPSIS 5 0.0005
439 RASH 236 0.0005
440 ARTHROPOD BITE 4 0.0005
441 NERVE INJURY 6 0.0005
442 NECROSIS 3 0.0005
443 RESPIRATORY TRACT INFECTION 14 0.0005
444 BLOOD UREA INCREASED 9 0.0005
445 DIARRHOEA HAEMORRHAGIC 5 0.0005
446 PRESYNCOPE 13 0.0005
447 DIARRHOEA 344 0.0005
448 PHOTOPHOBIA 10 0.0005
449 IMMUNE SYSTEM DISORDER 7 0.0005
450 PERIORBITAL SWELLING 3 0.0005
451 VOMITING 249 0.0005
452 OSTEOPENIA 8 0.0005
453 MALAISE 231 0.0005
454 HYPERTONIA 3 0.0005
455 MULTI-ORGAN FAILURE 9 0.0005
456 HAEMOLYSIS 4 0.0005
457 STRESS CARDIOMYOPATHY 3 0.0005
458 IMPAIRED GASTRIC EMPTYING 7 0.0005
459 HYPOVOLAEMIA 3 0.0005
460 DYSPNOEA 289 0.0005
461 HYPERCHLORHYDRIA 3 0.0005
462 DECREASED INTEREST 3 0.0005
463 CYANOSIS 8 0.0005
464 RESPIRATORY ARREST 14 0.0005
465 LIGAMENT SPRAIN 5 0.0005
466 DIZZINESS 252 0.0005
467 DYSPNOEA EXERTIONAL 19 0.0005
468 RENAL CYST 4 0.0005
469 TRICUSPID VALVE INCOMPETENCE 4 0.0005
470 HYPERLIPIDAEMIA 6 0.0005
471 SCIATICA 8 0.0005
472 GASTROOESOPHAGEAL REFLUX DISEASE 40 0.0005
473 NOCTURIA 6 0.0005
474 PANIC ATTACK 18 0.0005
475 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
476 POST PROCEDURAL INFECTION 4 0.0005
477 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
478 AGRANULOCYTOSIS 9 0.0005
479 SPINAL COMPRESSION FRACTURE 4 0.0005
480 LEUKOPENIA 24 0.0005
481 BLOOD URINE PRESENT 9 0.0005
482 CANDIDA INFECTION 8 0.0005
483 HALLUCINATION, VISUAL 10 0.0005
484 FACIAL PARALYSIS 4 0.0005
485 PSORIATIC ARTHROPATHY 19 0.0005
486 VITAMIN D DECREASED 4 0.0005
487 GENERAL PHYSICAL HEALTH DETERIORATION 54 0.0005
488 PSEUDOMONAS INFECTION 4 0.0005
489 HYPOGAMMAGLOBULINAEMIA 3 0.0005
490 BEDRIDDEN 6 0.0005
491 GASTRITIS 12 0.0005
492 ORAL CANDIDIASIS 6 0.0005
493 HYPOKALAEMIA 21 0.0005
494 COLD SWEAT 8 0.0005
495 IMMUNOSUPPRESSION 4 0.0005
496 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
497 LYMPHADENOPATHY 16 0.0005
498 OSTEOARTHRITIS 19 0.0004
499 FACIAL PAIN 4 0.0004
500 POST-TRAUMATIC STRESS DISORDER 3 0.0004
501 OROPHARYNGEAL DISCOMFORT 4 0.0004
502 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
503 ASCITES 13 0.0004
504 MITRAL VALVE INCOMPETENCE 5 0.0004
505 PALLOR 12 0.0004
506 IMPAIRED DRIVING ABILITY 5 0.0004
507 PREMATURE DELIVERY 7 0.0004
508 TACHYCARDIA 39 0.0004
509 PATHOGEN RESISTANCE 4 0.0004
510 DERMATITIS CONTACT 5 0.0004
511 RENAL INJURY 13 0.0004
512 ECCHYMOSIS 3 0.0004
513 SKIN LESION 12 0.0004
514 PANCREATITIS 23 0.0004
515 IRON DEFICIENCY ANAEMIA 4 0.0004
516 COUGH 121 0.0004
517 CONSTIPATION 94 0.0004
518 PRODUCT USE IN UNAPPROVED INDICATION 106 0.0004
519 FATIGUE 333 0.0004
520 SWELLING 40 0.0004
521 BLISTER 24 0.0004
522 FLANK PAIN 4 0.0004
523 SKIN REACTION 6 0.0004
524 PAPULE 3 0.0004
525 FOOT FRACTURE 8 0.0004
526 PYREXIA 146 0.0004
527 BLOOD PRESSURE DECREASED 28 0.0004
528 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
529 ARTHRITIS 33 0.0004
530 CARDIOGENIC SHOCK 6 0.0004
531 URINARY TRACT INFECTION 71 0.0004
532 PARAESTHESIA ORAL 6 0.0004
533 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
534 ORAL DISORDER 3 0.0004
535 POLLAKIURIA 17 0.0004
536 LIVER INJURY 10 0.0004
537 BLOOD BILIRUBIN INCREASED 11 0.0004
538 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
539 HEPATOMEGALY 4 0.0004
540 FOETAL EXPOSURE DURING PREGNANCY 33 0.0004
541 RASH PRURITIC 22 0.0004
542 CYST 5 0.0004
543 PULMONARY MASS 6 0.0004
544 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
545 THROAT IRRITATION 18 0.0004
546 HYDRONEPHROSIS 3 0.0004
547 OVARIAN CYST 4 0.0004
548 CHROMATURIA 9 0.0004
549 PREMATURE BABY 12 0.0004
550 HYPOAESTHESIA ORAL 6 0.0004
551 HYPOTHERMIA 4 0.0004
552 VISUAL ACUITY REDUCED 13 0.0004
553 SHOCK 9 0.0004
554 DRUG ADMINISTRATION ERROR 12 0.0004
555 RENAL FAILURE CHRONIC 3 0.0004
556 MUSCULAR WEAKNESS 44 0.0004
557 LEUKOCYTOSIS 7 0.0004
558 HEADACHE 242 0.0004
559 MULTIPLE ALLERGIES 3 0.0004
560 MOUTH ULCERATION 8 0.0004
561 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
562 PNEUMOTHORAX 6 0.0004
563 QUALITY OF LIFE DECREASED 5 0.0004
564 MENTAL IMPAIRMENT 9 0.0004
565 URINARY INCONTINENCE 11 0.0004
566 MUSCLE DISORDER 3 0.0004
567 INJURY 26 0.0004
568 UVEITIS 5 0.0004
569 BIPOLAR DISORDER 4 0.0004
570 BACK INJURY 4 0.0004
571 SEPTIC SHOCK 16 0.0004
572 ASPHYXIA 3 0.0004
573 POLYURIA 3 0.0004
574 ACUTE HEPATIC FAILURE 5 0.0004
575 GASTROINTESTINAL PAIN 4 0.0004
576 DYSGEUSIA 27 0.0004
577 DISCOMFORT 22 0.0004
578 COAGULOPATHY 6 0.0004
579 FUNGAL INFECTION 12 0.0004
580 FEELING COLD 10 0.0004
581 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
582 HAEMORRHOIDS 7 0.0004
583 CHOKING 7 0.0004
584 LIVE BIRTH 3 0.0004
585 RASH ERYTHEMATOUS 17 0.0004
586 ACCIDENTAL OVERDOSE 13 0.0004
587 LYMPHOPENIA 5 0.0004
588 DIALYSIS 5 0.0004
589 ERYTHEMA 72 0.0003
590 SPINAL FRACTURE 7 0.0003
591 PARALYSIS 5 0.0003
592 ANURIA 3 0.0003
593 RASH GENERALISED 9 0.0003
594 FULL BLOOD COUNT DECREASED 7 0.0003
595 CARDIAC MURMUR 3 0.0003
596 FEELING HOT 21 0.0003
597 DYSSTASIA 10 0.0003
598 SPLENOMEGALY 4 0.0003
599 SPINAL PAIN 4 0.0003
600 OSTEOPOROSIS 14 0.0003
601 ASPARTATE AMINOTRANSFERASE INCREASED 18 0.0003
602 WRIST FRACTURE 4 0.0003
603 THYROID CANCER 4 0.0003
604 SEPSIS 37 0.0003
605 LUPUS-LIKE SYNDROME 3 0.0003
606 HERPES ZOSTER 19 0.0003
607 PNEUMONITIS 9 0.0003
608 C-REACTIVE PROTEIN INCREASED 12 0.0003
609 SYNCOPE 33 0.0003
610 SKIN DISORDER 11 0.0003
611 INFLAMMATION 17 0.0003
612 DYSURIA 12 0.0003
613 MUSCLE SPASTICITY 4 0.0003
614 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
615 RHINORRHOEA 21 0.0003
616 SURGERY 19 0.0003
617 PRURITUS GENERALISED 7 0.0003
618 LIMB DISCOMFORT 10 0.0003
619 GENERALISED OEDEMA 4 0.0003
620 BACK PAIN 75 0.0003
621 PHARYNGITIS 4 0.0003
622 LOSS OF CONSCIOUSNESS 41 0.0003
623 BLINDNESS 13 0.0003
624 BRAIN FOG 5 0.0003
625 SQUAMOUS CELL CARCINOMA 3 0.0003
626 PRODUCT USE COMPLAINT 5 0.0003
627 PROTEINURIA 6 0.0003
628 CARDIOVASCULAR DISORDER 8 0.0003
629 RESPIRATORY TRACT CONGESTION 5 0.0003
630 INCREASED APPETITE 6 0.0003
631 OBESITY 5 0.0003
632 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
633 RASH PAPULAR 7 0.0003
634 SENSORY DISTURBANCE 5 0.0003
635 MOVEMENT DISORDER 10 0.0003
636 INFUSION SITE PAIN 4 0.0003
637 SKIN ULCER 8 0.0003
638 LIVER FUNCTION TEST ABNORMAL 9 0.0003
639 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
640 PLATELET COUNT INCREASED 4 0.0003
641 RENAL TUBULAR NECROSIS 3 0.0003
642 COELIAC DISEASE 3 0.0003
643 DYSPEPSIA 30 0.0003
644 HOSPICE CARE 3 0.0003
645 ANKYLOSING SPONDYLITIS 4 0.0003
646 HEART RATE INCREASED 30 0.0003
647 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
648 HYPERTENSION 64 0.0003
649 TREATMENT FAILURE 25 0.0003
650 ADVERSE REACTION 4 0.0003
651 CYTOMEGALOVIRUS INFECTION 5 0.0003
652 PALPITATIONS 35 0.0003
653 THROAT TIGHTNESS 8 0.0003
654 PRODUCT PRESCRIBING ERROR 7 0.0003
655 ANAEMIA 56 0.0003
656 HEPATIC ENZYME INCREASED 20 0.0003
657 INITIAL INSOMNIA 3 0.0003
658 HAEMATURIA 10 0.0003
659 PERIPHERAL COLDNESS 4 0.0003
660 PLATELET COUNT DECREASED 31 0.0003
661 COLITIS ULCERATIVE 13 0.0003
662 RESPIRATORY DISTRESS 8 0.0003
663 TENDERNESS 3 0.0003
664 MUSCULOSKELETAL STIFFNESS 25 0.0003
665 BLOOD TEST ABNORMAL 4 0.0003
666 INCONTINENCE 3 0.0003
667 DRY MOUTH 23 0.0003
668 SEASONAL ALLERGY 4 0.0003
669 HEAD DISCOMFORT 5 0.0003
670 PNEUMONIA ASPIRATION 7 0.0003
671 PLEURAL EFFUSION 17 0.0003
672 PERIPHERAL SWELLING 43 0.0003
673 HYPERSOMNIA 8 0.0003
674 POOR QUALITY SLEEP 6 0.0003
675 DECREASED ACTIVITY 3 0.0003
676 CELLULITIS 14 0.0003
677 SKIN LACERATION 3 0.0003
678 ARRHYTHMIA 13 0.0003
679 CHOLELITHIASIS 9 0.0003
680 DYSPHAGIA 26 0.0003
681 CHILLS 32 0.0003
682 CARDIOMYOPATHY 4 0.0003
683 OROPHARYNGEAL PAIN 25 0.0003
684 BACTERIAL INFECTION 5 0.0003
685 DEAFNESS 7 0.0003
686 ARTHRALGIA 111 0.0003
687 OXYGEN SATURATION DECREASED 15 0.0003
688 BLOOD CALCIUM DECREASED 3 0.0003
689 HEPATIC FAILURE 8 0.0003
690 HYPOTENSION 53 0.0003
691 VERTIGO 16 0.0003
692 FEELING JITTERY 5 0.0003
693 NEPHROLITHIASIS 12 0.0003
694 SKIN DISCOLOURATION 12 0.0003
695 PHARYNGEAL OEDEMA 4 0.0003
696 DEVICE RELATED INFECTION 4 0.0003
697 METASTASES TO LUNG 3 0.0003
698 RENAL FAILURE ACUTE 11 0.0003
699 ELECTROLYTE IMBALANCE 3 0.0003
700 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
701 MOOD ALTERED 7 0.0003
702 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
703 HAEMATOCHEZIA 14 0.0003
704 MENTAL DISORDER 11 0.0003
705 NAUSEA 200 0.0003
706 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
707 DISORIENTATION 10 0.0003
708 HAEMATOCRIT DECREASED 5 0.0003
709 MYOCLONUS 3 0.0003
710 METABOLIC ACIDOSIS 8 0.0002
711 ABORTION SPONTANEOUS 10 0.0002
712 HYPOGLYCAEMIA 12 0.0002
713 ADRENAL INSUFFICIENCY 3 0.0002
714 NEURALGIA 6 0.0002
715 ATRIAL FIBRILLATION 24 0.0002
716 NO THERAPEUTIC RESPONSE 3 0.0002
717 CARDIOMEGALY 3 0.0002
718 SMALL INTESTINAL OBSTRUCTION 3 0.0002
719 METASTASES TO BONE 4 0.0002
720 IMPAIRED HEALING 8 0.0002
721 STAPHYLOCOCCAL INFECTION 8 0.0002
722 INFLUENZA 27 0.0002
723 EYE SWELLING 9 0.0002
724 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
725 PARAESTHESIA 38 0.0002
726 VIRAL INFECTION 8 0.0002
727 DEHYDRATION 32 0.0002
728 DYSARTHRIA 9 0.0002
729 TYPE 2 DIABETES MELLITUS 8 0.0002
730 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
731 JOINT INJURY 5 0.0002
732 IMPAIRED WORK ABILITY 5 0.0002
733 RECTAL HAEMORRHAGE 10 0.0002
734 NECK PAIN 13 0.0002
735 HYPOACUSIS 10 0.0002
736 EMOTIONAL DISTRESS 28 0.0002
737 FAECES DISCOLOURED 5 0.0002
738 CARDIAC ARREST 19 0.0002
739 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
740 BLOOD CREATININE INCREASED 15 0.0002
741 PRODUCT PRESCRIBING ISSUE 5 0.0002
742 EPILEPSY 7 0.0002
743 TREMOR 38 0.0002
744 RASH MACULAR 8 0.0002
745 METASTASES TO LIVER 4 0.0002
746 PULMONARY CONGESTION 3 0.0002
747 HYPOAESTHESIA 34 0.0002
748 SOPOR 3 0.0002
749 FLUSHING 23 0.0002
750 RENAL IMPAIRMENT 19 0.0002
751 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
752 TRANSAMINASES INCREASED 5 0.0002
753 CHEST DISCOMFORT 23 0.0002
754 HAEMOGLOBIN DECREASED 23 0.0002
755 BONE DENSITY DECREASED 7 0.0002
756 GLOSSODYNIA 5 0.0002
757 SNEEZING 5 0.0002
758 DISTURBANCE IN ATTENTION 12 0.0002
759 PANCREATITIS ACUTE 5 0.0002
760 PSORIASIS 29 0.0002
761 OFF LABEL USE 194 0.0002
762 OEDEMA PERIPHERAL 27 0.0002
763 HOSPITALISATION 34 0.0002
764 NASAL CONGESTION 13 0.0002
765 TOOTHACHE 4 0.0002
766 HYPERGLYCAEMIA 8 0.0002
767 HIP FRACTURE 7 0.0002
768 DIVERTICULITIS 6 0.0002
769 PERICARDIAL EFFUSION 5 0.0002
770 MEDICATION ERROR 12 0.0002
771 CONJUNCTIVITIS 4 0.0002
772 ABDOMINAL DISCOMFORT 36 0.0002
773 THERAPEUTIC RESPONSE DECREASED 13 0.0002
774 HEPATIC CIRRHOSIS 4 0.0002
775 ANGINA PECTORIS 6 0.0002
776 POST PROCEDURAL COMPLICATION 4 0.0002
777 LOWER LIMB FRACTURE 4 0.0002
778 ACUTE RESPIRATORY FAILURE 4 0.0002
779 BRADYCARDIA 11 0.0002
780 ANOSMIA 3 0.0002
781 ERUCTATION 4 0.0002
782 APATHY 3 0.0002
783 DRUG INEFFECTIVE 271 0.0002
784 ORAL HERPES 4 0.0002
785 BONE PAIN 12 0.0002
786 KIDNEY INFECTION 4 0.0002
787 DELIRIUM 7 0.0002
788 MUSCLE SPASMS 37 0.0002
789 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
790 UPPER LIMB FRACTURE 4 0.0002
791 AGEUSIA 5 0.0002
792 INFECTION 29 0.0002
793 ASTHENIA 75 0.0002
794 HEART RATE DECREASED 7 0.0002
795 LACRIMATION INCREASED 6 0.0002
796 ABDOMINAL PAIN LOWER 5 0.0002
797 HYPOPHAGIA 5 0.0002
798 HYPONATRAEMIA 11 0.0002
799 PRODUCT PREPARATION ERROR 4 0.0002
800 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
801 RIB FRACTURE 4 0.0002
802 FEMUR FRACTURE 6 0.0002
803 UNRESPONSIVE TO STIMULI 5 0.0002
804 PAIN 119 0.0002
805 TOOTH LOSS 4 0.0002
806 ACUTE MYELOID LEUKAEMIA 3 0.0002
807 THERAPY PARTIAL RESPONDER 3 0.0002
808 NERVOUSNESS 10 0.0002
809 DERMATITIS 4 0.0002
810 JOINT SWELLING 23 0.0002
811 INTERSTITIAL LUNG DISEASE 9 0.0002
812 HOT FLUSH 14 0.0002
813 MUSCLE TIGHTNESS 3 0.0002
814 VAGINAL HAEMORRHAGE 8 0.0002
815 FEBRILE NEUTROPENIA 12 0.0002
816 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
817 LIVER DISORDER 8 0.0002
818 DRY EYE 9 0.0002
819 PROCEDURAL PAIN 5 0.0002
820 SOMNOLENCE 36 0.0002
821 PULMONARY OEDEMA 8 0.0002
822 ORAL PAIN 4 0.0002
823 RESPIRATORY FAILURE 13 0.0002
824 VISUAL IMPAIRMENT 22 0.0002
825 HEART RATE IRREGULAR 4 0.0002
826 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
827 BLOOD PRESSURE INCREASED 27 0.0002
828 FLATULENCE 10 0.0002
829 RHEUMATOID ARTHRITIS 20 0.0002
830 SCAR 3 0.0002
831 ILLNESS 18 0.0002
832 MUSCULOSKELETAL DISCOMFORT 3 0.0002
833 CONFUSIONAL STATE 28 0.0002
834 ORTHOSTATIC HYPOTENSION 3 0.0002
835 LOCAL SWELLING 3 0.0002
836 RENAL DISORDER 8 0.0002
837 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
838 NEUROTOXICITY 3 0.0002
839 HYPERKALAEMIA 6 0.0002
840 PRODUCT DOSE OMISSION 11 0.0002
841 NEUROPATHY PERIPHERAL 16 0.0002
842 DISEASE RECURRENCE 8 0.0002
843 GALLBLADDER DISORDER 3 0.0002
844 RESPIRATORY DISORDER 5 0.0002
845 BLOOD PRESSURE FLUCTUATION 4 0.0002
846 MYELOSUPPRESSION 6 0.0002
847 SYNOVITIS 3 0.0002
848 IRRITABILITY 10 0.0002
849 BLOOD POTASSIUM DECREASED 5 0.0002
850 TOXICITY TO VARIOUS AGENTS 28 0.0002
851 LOCALISED INFECTION 4 0.0002
852 PELVIC PAIN 3 0.0002
853 CRYING 6 0.0002
854 RESTLESS LEGS SYNDROME 3 0.0002
855 INJECTION SITE BRUISING 13 0.0002
856 NASOPHARYNGITIS 30 0.0002
857 FALL 54 0.0002
858 EMOTIONAL DISORDER 5 0.0002
859 EXTRAPYRAMIDAL DISORDER 4 0.0002
860 HEPATIC STEATOSIS 3 0.0002
861 THINKING ABNORMAL 3 0.0002
862 THROMBOCYTOPENIA 18 0.0002
863 HEPATIC FUNCTION ABNORMAL 6 0.0002
864 HYPOCALCAEMIA 3 0.0002
865 FRACTURE 3 0.0002
866 GASTRIC ULCER 3 0.0002
867 HAEMATEMESIS 4 0.0002
868 WEIGHT DECREASED 44 0.0002
869 BURNING SENSATION 11 0.0002
870 WHITE BLOOD CELL COUNT DECREASED 17 0.0002
871 GASTROINTESTINAL DISORDER 14 0.0002
872 CONTUSION 15 0.0002
873 HAEMATOMA 4 0.0002
874 DEEP VEIN THROMBOSIS 10 0.0002
875 ECZEMA 8 0.0002
876 OSTEONECROSIS 5 0.0002
877 SINUS DISORDER 3 0.0002
878 CATARACT 9 0.0002
879 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
880 PRESCRIBED UNDERDOSE 3 0.0002
881 BLOOD CHOLESTEROL INCREASED 7 0.0002
882 URINARY RETENTION 5 0.0001
883 GAIT INABILITY 5 0.0001
884 FEAR 4 0.0001
885 PRODUCT ADMINISTRATION ERROR 3 0.0001
886 SUICIDE ATTEMPT 9 0.0001
887 FREQUENT BOWEL MOVEMENTS 4 0.0001
888 FEEDING DISORDER 3 0.0001
889 BONE MARROW FAILURE 3 0.0001
890 NEUTROPHIL COUNT DECREASED 6 0.0001
891 COMA 7 0.0001
892 GAIT DISTURBANCE 28 0.0001
893 ABNORMAL DREAMS 4 0.0001
894 MENTAL STATUS CHANGES 4 0.0001
895 DECREASED APPETITE 33 0.0001
896 PAIN IN JAW 4 0.0001
897 EATING DISORDER 3 0.0001
898 LIVER FUNCTION TEST INCREASED 3 0.0001
899 SKIN BURNING SENSATION 10 0.0001
900 LETHARGY 8 0.0001
901 INSOMNIA 37 0.0001
902 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
903 MELAENA 3 0.0001
904 PSYCHOTIC DISORDER 4 0.0001
905 ADVERSE DRUG REACTION 12 0.0001
906 THERAPY NON-RESPONDER 6 0.0001
907 ALOPECIA 26 0.0001
908 NEUTROPENIA 18 0.0001
909 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
910 CORONARY ARTERY DISEASE 4 0.0001
911 CHEST PAIN 24 0.0001
912 OEDEMA 7 0.0001
913 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
914 CARDIAC DISORDER 12 0.0001
915 PLASMA CELL MYELOMA 5 0.0001
916 BALANCE DISORDER 11 0.0001
917 OCULAR HYPERAEMIA 6 0.0001
918 EPISTAXIS 9 0.0001
919 COVID-19 21 0.0001
920 UNEVALUABLE EVENT 9 0.0001
921 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
922 GASTRIC CANCER 3 0.0001
923 DEATH 102 0.0001
924 INCORRECT DOSE ADMINISTERED 27 0.0001
925 PRODUCT QUALITY ISSUE 16 0.0001
926 GASTRIC DISORDER 4 0.0001
927 NIGHTMARE 4 0.0001
928 JOINT STIFFNESS 3 0.0001
929 DEPRESSED MOOD 6 0.0001
930 SEIZURE 13 0.0001
931 CARDIAC FAILURE CONGESTIVE 9 0.0001
932 CEREBRAL HAEMORRHAGE 4 0.0001
933 MOBILITY DECREASED 8 0.0001
934 INTENTIONAL OVERDOSE 7 0.0001
935 PRODUCT DOSE OMISSION ISSUE 32 0.0001
936 PANCYTOPENIA 6 0.0001
937 DEMENTIA 3 0.0001
938 OVERDOSE 23 0.0001
939 COLITIS 4 0.0001
940 RED BLOOD CELL COUNT DECREASED 3 0.0001
941 CONVULSION 6 0.0001
942 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
943 ABNORMAL BEHAVIOUR 4 0.0001
944 AGGRESSION 5 0.0001
945 APHASIA 3 0.0001
946 NERVOUS SYSTEM DISORDER 3 0.0001
947 ROAD TRAFFIC ACCIDENT 4 0.0001
948 HEAD INJURY 3 0.0001
949 WEIGHT INCREASED 21 0.0001
950 NIGHT SWEATS 3 0.0001
951 DRUG EFFECT DECREASED 5 0.0001
952 LACTIC ACIDOSIS 3 0.0001
953 AMNESIA 6 0.0001
954 DIABETES MELLITUS 7 0.0001
955 TREATMENT NONCOMPLIANCE 5 0.0001
956 EYE DISORDER 3 0.0001
957 PRODUCT USE ISSUE 17 0.0001
958 EYE PRURITUS 3 0.0001
959 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
960 MEMORY IMPAIRMENT 12 0.0001
961 SKIN IRRITATION 4 0.0001
962 PRODUCT SUBSTITUTION ISSUE 5 0.0001
963 COGNITIVE DISORDER 4 0.0001
964 DRUG ABUSE 7 0.0001
965 NO ADVERSE EVENT 15 0.0001
966 SUICIDAL IDEATION 7 0.0001
967 SPEECH DISORDER 4 0.0001
968 ADVERSE EVENT 7 0.0001
969 DRY SKIN 10 0.0001
970 CARDIAC FAILURE 6 0.0001
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
972 DEVICE BREAKAGE 3 0.0001
973 DYSKINESIA 3 0.0001
974 LUNG NEOPLASM MALIGNANT 3 0.0001
975 INFLUENZA LIKE ILLNESS 6 0.0001
976 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
977 ARTHROPATHY 4 0.0001
978 RHABDOMYOLYSIS 3 0.0001
979 CEREBROVASCULAR ACCIDENT 12 0.0001
980 DRUG DEPENDENCE 11 0.0001
981 DISEASE PROGRESSION 8 0.0001
982 ILL-DEFINED DISORDER 4 0.0001
983 INJECTION SITE SWELLING 5 0.0001
984 BLOOD GLUCOSE INCREASED 12 0.0001
985 EYE PAIN 3 0.0001
986 HAEMORRHAGE 5 0.0000
987 DRUG WITHDRAWAL SYNDROME 4 0.0000
988 INJECTION SITE PRURITUS 3 0.0000
989 THERAPY INTERRUPTED 3 0.0000
990 ACNE 3 0.0000
991 PROSTATE CANCER 3 0.0000
992 INTENTIONAL PRODUCT MISUSE 3 0.0000
993 DRUG DOSE OMISSION 5 0.0000
994 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
995 INJECTION SITE PAIN 8 0.0000